Akt activation is a significant predictor of global histone acetylation levels in glioma cells via Akt-dependent metabolic reprogramming to increase acetyl-CoA synthesis, and histone acetylation level is a valuable biomarker for predicting tumor recurrence [35]. The gene discussed is AKT1; the disease is central nervous system cancer.